The INKEF Capital Team, our DNA
Over the years we have built a dynamic team eager to discover new technologies and build successful companies worldwide. We embrace the great challenge of transforming early-stage tractions into successful businesses. Our team is diverse, as it should be, but we are united by the energy and enthusiasm to succeed. It is our business to help you fulfil your entrepreneurial dream. If we can contribute to making the world a better place in the process, so much the better.
Michael Stam became INKEF’s Chief Executive Officer in August 2012. As a chair member of our Investment Committee and representative of our founding partner ABP, Michael has been closely associated with INKEF since its inception in 2010. Previously, Michael managed APG’s Listed Equity Platform, focusing on selecting and monitoring external asset managers.
Michael received a Bachelor’s degree in Law from the University of Leiden, an MBA from Delft University and a Master’s in Real Estate from the Amsterdam School of Real Estate.
Jan Keltjens joined INKEF in September 2015. Jan has extensive experience in the health care sector. He most recently served as chief executive officer of Sapiens Steering Brain Stimulation (acquired by Medtronic in August 2014). Before that he previously was the chairman and chief executive officer of Endosense SA (acquired by St Jude Medical in August 2013), executive chairman of Surpass Medical ltd. (acquired by Stryker Corporation late 2012), as well as president and chief executive officer of AngioDynamics Inc. (ANGO, 2009 – 2011) and CryoCath Technologies Inc. (TSX; CYT, 2007- until its acquisition by Medtronic in 2009). From 2000 to 2007, he served as Worldwide General Manager of Cordis Neurovascular, a Johnson & Johnson company.
Jan currently holds a number of non-executive Board roles, including Chairman of the Board of JenaValve Technologies.